Despite the small sample size, the significant associations with age, tumour location, and histological type underscore the need for larger, more comprehensive studies to further elucidate the role of E-cadherin in gastric cancer pathogenesis and its potential as a therapeutic target. This evidence concerns the gene CDH1 and neoplasm.